Should relapsing cytomegalovirus infection in liver transplant recipients be treated?;Skal recidiverende Cytomegalovirus-infektioner hos levertransplanterede patienter behandles?

Ugeskrift for Laeger

Volumn 159, Issue 22, 1997, Pages 3413-3416

  Tarp, Britta D ^a   Astrup, Lone B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; BLOOD ANALYSIS; CASE REPORT; CYTOMEGALOVIRUS INFECTION; FEMALE; HUMAN; IMMUNE RESPONSE; LIVER BIOPSY; LIVER TRANSPLANTATION; ORAL DRUG ADMINISTRATION; RELAPSE;

ADULT; ANTIGENS, VIRAL; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; RECURRENCE;

EID: 0030952145     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Lautenschlager I, Höckerstedt K, Salmela K. Quantitative CMV-antigenemia test in the diagnosis of CMV infection and in the monitoring of response to antiviral treatment in liver transplant recipients. Transplant Proc 1994; 3: 1719-20.
2. Sigh N, Mieles L, Yu VL, Starzl TE. Decreased incidence of viral infections in liver transplant recipients. Possible effects of FK506? Dig Dis Sci 1994; 39: 15-8.
3. Pillay D, Charman H, Burroughs AK, Smith M, Rolles K, Griffiths PD. Surveillance for CMV infection in orthotopic liver transplant recipients. Transplantation 1992; 53: 1261-5.
4. Schiffer V, Mentha G, Giosta E, Belli D, Le Coultre C, Rohner A. Le Cytomégalovirus chez les transplantés du foie: incidence et groupes à risques. Schweiz Med Wochenschr 1994; 124: 631-6.
5. Barkholt LM, Ericzon B-G, Ehrnst A, Forsgren M, Anderson JP. Cytomegalovirus infections in liver transplant patients: incidence and outcome. Transplant Proc 1990; 22: 235-7.
6. Wiesner RH, Marin E, Porayko MK, Steers JL, Krom RAF, Paya CV. Advances in the diagnosis, treatment, and prevention of Cytomegalovirus infections after liver transplantation. Gastroenterol Clin North Am 1993; 22: 351-66.
7. Stratta RJ, Shaefer MS, Markin RS, Cushing KA, Donovan JP, Wood RP et al. Ganciclovir therapy for viral disease in liver transplant recipients. Clin Transplant 1991; 5: 287-93.
8. Van den Berg AP, Van Son WJ, Haagsma EB, Klompmaker U, Tegrzess AM, Schirm J et al. Prediction of recurrent Cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. Transplantation 1993; 55: 847-51.
9. Bowden RA, Digel J, Reed EC, Meyers JD. Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses. J Infect Dis 1989; 156: 899.
10. Paya CV, Hermans PE, Wiesner RH. Cytomegalovirus hepatitis in liver transplantation: prospective analysis of 93 consecutive orthotopic liver transplantations. J Infect Dis 1989; 160: 752.